Re: Neoadjuvant hormonal ablative therapy before radical, prostatectomy: A review. Is it indicated?

被引：0
|
作者：
Neulander, EZ [1 ]
Rivera, I [1 ]
Wajsman, Z [1 ]
机构：
[1] Univ Florida, Div Urol, Gainesville, FL 32611 USA
来源：
JOURNAL OF UROLOGY | 2001年 / 165卷 / 06期
关键词：
D O I：
10.1016/S0022-5347(05)66281-7
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2008 / 2008
页数：1
相关论文
共 50 条
  • [21] Neoadjuvant hormonal therapy prior to radical prostatectomy: promises and pitfalls
    Gleave, ME
    La Bianca, S
    Goldenberg, SL
    PROSTATE CANCER AND PROSTATIC DISEASES, 2000, 3 (03) : 136 - 144
  • [22] Neoadjuvant hormonal therapy and radical prostatectomy for locally advanced prostate cancer
    Pansadoro, V
    Sternberg, CN
    MOLECULAR UROLOGY, 1999, 3 (03) : 271 - 274
  • [23] Neoadjuvant hormonal therapy in radical prostatectomy and radiation-treated patients
    Schmid, HP
    Semjonow, A
    Aus, G
    Hertle, L
    UROLOGIA INTERNATIONALIS, 2000, 65 (02) : 63 - 67
  • [24] The survival impact of neoadjuvant hormonal therapy before radical prostatectomy for treatment of high-risk prostate cancer
    Tosco, L.
    Laenen, A.
    Briganti, A.
    Gontero, P.
    Karnes, R. J.
    Albersen, M.
    Bastian, P. J.
    Chlosta, P.
    Claessens, F.
    Chun, F. K.
    Everaerts, W.
    Gratzke, C.
    Graefen, M.
    Kneitz, B.
    Marchioro, G.
    Salas, R. S.
    Tombal, B.
    Van den Broeck, T.
    Moris, L.
    Battaglia, A.
    Van der Poel, H.
    Walz, J.
    Bossi, A.
    De Meerleer, G.
    Haustermans, K.
    Van Poppel, H.
    Spahn, M.
    Joniau, S.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2017, 20 (04) : 407 - 412
  • [25] The survival impact of neoadjuvant hormonal therapy before radical prostatectomy for treatment of high-risk prostate cancer
    L Tosco
    A Laenen
    A Briganti
    P Gontero
    R J Karnes
    M Albersen
    P J Bastian
    P Chlosta
    F Claessens
    F K Chun
    W Everaerts
    C Gratzke
    M Graefen
    B Kneitz
    G Marchioro
    R S Salas
    B Tombal
    T Van den Broeck
    L Moris
    A Battaglia
    H van der Poel
    J Walz
    A Bossi
    G De Meerleer
    K Haustermans
    H Van Poppel
    M Spahn
    S Joniau
    Prostate Cancer and Prostatic Diseases, 2017, 20 : 407 - 412
  • [26] Neoadjuvant chemotherapy and hormonal therapy followed by radical prostatectomy: Feasibility and preliminary results
    Pettaway, CA
    Pisters, LL
    Troncoso, P
    Slaton, J
    Finn, L
    Kamoi, K
    Logothetis, CJ
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (05) : 1050 - 1057
  • [27] Neoadjuvant hormonal therapy delays recovery of quality of life after radical prostatectomy
    Namiki, S
    Arai, Y
    Kuwahara, M
    Ioritani, N
    Terai, A
    JOURNAL OF UROLOGY, 2004, 171 (04): : 277 - 278
  • [28] Neoadjuvant Chemohormonal Therapy in Prostate Cancer Before Radical Prostatectomy: A Systematic Review and Meta-Analysis
    Ge, Qingyu
    Xu, Hewei
    Yue, Dezhou
    Fan, Zongyao
    Chen, Zhengsen
    Xu, Jie
    Zhou, Yiduo
    Zhang, Sicong
    Xue, Jun
    Shen, Baixin
    Wei, Zhongqing
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [29] Neoadjuvant hormonal deprivation for patients undergoing radical prostatectomy
    Gao, Xu
    Zhou, Tie
    Tang, Yuan-Jie
    Lu, Xin
    Sun, Ying-Hao
    ASIAN JOURNAL OF ANDROLOGY, 2009, 11 (01) : 127 - 130
  • [30] Predictors of pathological stage before neoadjuvant androgen withdrawal therapy and radical prostatectomy
    Rabbani, F
    Goldenberg, SL
    Klotz, LH
    JOURNAL OF UROLOGY, 1998, 159 (03): : 925 - 928
12345